Kosuke Mizutani

5PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Particle physicsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 24, 2022
Genomic landscape of treatment-naïve urological cancers using next-generation sequencing-based panel test in the Japanese population.

Kosuke Mizutani, Kouseki Hirade, Seiji Sugiyama

|Apr 27, 2021
Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel-resistant prostate cancer.

Seiji Hishida, Kyojiro Kawakami, Yasunori Fujita

|Mar 31, 2021
Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab.

Kosuke Mizutani, Toshiki Ito, Kiyoshi Takahara

|Mar 01, 2019
Urinary exosome as a potential biomarker for urinary tract infection.

Kosuke Mizutani, Kyojiro Kawakami, Kengo Horie

|Dec 06, 2018
Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy.

Kosuke Mizutani, Kengo Horie, Taku Kato

Pageof 1

Frequent Collaborators